Kariya Pharmaceuticals ApS — Credit Rating and Financial Key Figures

Kariya Pharmaceuticals ApS (CVR number: 39270684) is a company from KØBENHAVN. The company recorded a gross profit of -3624.7 kDKK in 2024. The operating profit was -4341 kDKK, while net earnings were -2599.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -81 %, which can be considered poor and Return on Equity (ROE) was -158.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 55.7 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Kariya Pharmaceuticals ApS's liquidity measured by quick ratio was 2.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.